Diabetes Mellitus Clinical Trial
Official title:
Can Videolaryngoscopy be the First Choice for Tracheal Intubation in Patients With Diabetes
The use of videolarygoscopy (VL) as first choice for tracheal intubation versus direct laryngoscopy (DL) is a matter of debate. These two methods were compared in several studies. Videolaryngoscopes may reduce the number of failed intubations, particularly among patients presenting with a difficult airway. They improve the glottic view and may reduce airway trauma. DM is accepted as a risk factor for difficult intubation. The aim of this study is to compare VL to DL in adult patients requiring tracheal intubation for anesthesia, in terms of intubation success, glottic view quality, intubation failure, intubation time, conversion to another laringoscopy method and adverse outcomes related to tracheal intubation.
The use of videolarygoscopy (VL) as first choice for tracheal intubation versus direct
laryngoscopy (DL) is a matter of debate. These two methods were compared in several studies.
First attempt intubation success and glottic visualization with VL versus DL by pediatric
emergency medicine providers in simulated patients were evaluated and it was concluded that
VL was associated with greater first-attempt success during intubation by pediatric emergency
physicians on an adult simulator. The ease of viewing the glottis under direct vision during
conventional laryngoscopy with the quality of indirectly viewing on a monitor during
laryngoscopy with a Macintosh videolaryngoscope was compared in a multicenter study. The
results were that VL can lead to better viewing conditions but in rare cases it may result in
worse viewing conditions. The study evaluating the efficacy and safety of VL compared to DL
in decreasing the time and attempts required and increasing the success rate for endotracheal
intubation in neonates concluded that there was insufficient evidence to recommend or refute
the use of VL for endotracheal intubation in neonates. Diverse videolaryngoscopes where also
compared in patients undergoing tracheal intubation for elective surgery: the GlideScope
Ranger (GlideScope, Bothell, WA), the V-MAC Storz Berci DCI (Karl Storz, Tuttlingen,
Germany), and the McGrath (McGrath series 5, Aircraft medical, Edinburgh, UK) and tested
whether it is feasible to intubate the trachea of patients with indirect videolaryngoscopy
without using a stylet. The authors concluded that the trachea of a large proportion of
patients with normal airways can be intubated successfully with certain VL blades without
using a stylet, although the three studied VL's clearly differ in outcome. The Storz VL
displaces soft tissues in the fashion of a classic Macintosh scope, affording room for
tracheal tube insertion and limiting the need for stylet use compared with the other two
scopes. Although VL's offer several advantages, including better visualization of the glottic
entrance and intubation conditions, a good laryngeal view does not guarantee easy or
successful tracheal tube insertion. Three different videolarygoscope devices were compared to
direct laringoscopy in obese patients undergoing bariatric surgery: Video Mac and GlideScope
required fewer intubation attempts that DL and Video Mac provide shorter intubation times and
improved glottis view compared to DL. A recent metanalysis stated that videolaryngoscopes may
reduce the number of failed intubations, particularly among patients presenting with a
difficult airway. They improve the glottic view and may reduce laryngeal/airway trauma.
However currently, no evidence indicates that use of a VLS reduces the number of intubation
attempts or the incidence of hypoxia or respiratory complications, and no evidence indicates
that use of a VL's affects time required for intubation. DM is accepted as a risk factor for
difficult intubation.
The aim of this study is to compare VL to DL in adult diabetic patients requiring tracheal
intubation for anesthesia, in terms of intubation time, intubation success, glottic view
quality, intubation failure, conversion to another laringoscopy method and adverse outcomes
related to tracheal intubation.
METHODS After obtaining ethical approval and written informed patient consent, consecutive
patients having diabetes mellitus (DM) and requiring elective intubation for anesthesia will
be randomly allocated to either the videolaryngoscopy (Group VL) or the direct larngoscopy
(Macintosh laryngoscope) (Group DL). Age, gender, body mass index, American Society of
Anesthesiologists (ASA) physiologic classification, the duration of DM will be recorded. The
patients will be evaluated for difficult airway predictors and the following parameters will
be recorded: Malampati class, thyromental distance, sternomental distance, mandibulohyoid
distance, interincisor distance, neck circumference, the ability of upper lip overbite and
lower lip overbite, the presence of limited neck extension. Fentanyl-propofol-rocuronium will
be used for anesthesia induction. After subsequent positive-pressure ventilation using a face
mask and an oxygen-air-sevoflurane mixture for 3 min, the trachea will be intubated according
to group allocation using either DL (Macintosh laryngoscope) or VL (CMAC). During intubation,
the following data will be documented: intubation time, number of intubation attempts, use of
extra tools to facilitate intubation, conversion to another laryngoscopy method,intubation
difficulty and the quality of the view of the glottis will be assessed according to the
Cormack and Lehane scoring system and the percentage of glottic opening. Adverse events
related to tracheal intubation will be also evaluated: desaturation (SPO2<94), hypercabia
(ETCO2>35), hypertension (mean arterial pressure >20% above baseline values), tachycardia
(heart rate >20% above baseline values), new onset arrhythmia, laryngospasm, bronchospasm,
airway trauma and sore throat in PACU). The primary outcome measure is the time to
intubation; first-attempt intubation success and ease of intubation, secondary outcome
measures are the glottic view guality, conversion to another laryngoscopy method and adverse
outcomes related to tracheal intubation.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
| Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
| Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
| Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
| Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
| Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
| Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
| Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
| Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
| Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
| Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
| Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
| Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
| Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
| Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |